Tag: MSK immunotherapy trial
-
Major Cancer Breakthrough in the U.S.! 14 Rectal Cancer Patients Achieve 100% Remission – All Traces of Cancer Gone!
A heartwarming moment recently took place at New York’s Memorial Sloan Kettering Cancer Center (MSK): a rectal cancer patient called his mother, and together, they cried tears of joy over the phone. MSK’s groundbreaking clinical trial, which employed an innovative immunotherapy, achieved 100% remission in 14 rectal cancer patients, with no cancer remaining. Experts are… Read more